搜索
Relay Therapeutics Inc
RLAY添加自选
18.840USD
-0.350-1.82%
收盘 09-18 16:00（美东）
4.12B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
SB Investment Advisers (UK) Limited
14.57%
Commodore Capital LP
8.87%
Point72 Asset Management, L.P.
7.23%
Casdin Capital, LLC
6.79%
BlackRock Institutional Trust Company, N.A.
5.49%
其他
57.05%
持股股东
持股股东
占比
SB Investment Advisers (UK) Limited
14.57%
Commodore Capital LP
8.87%
Point72 Asset Management, L.P.
7.23%
Casdin Capital, LLC
6.79%
BlackRock Institutional Trust Company, N.A.
5.49%
其他
57.05%
股东类型
持股股东
占比
Hedge Fund
30.37%
Investment Advisor
29.72%
Private Equity
15.32%
Investment Advisor/Hedge Fund
12.47%
Research Firm
1.99%
Individual Investor
1.58%
Venture Capital
0.90%
Sovereign Wealth Fund
0.44%
Family Office
0.33%
其他
6.88%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
474
194.30M
101.48%
-3.65M
2025Q4
458
170.00M
98.08%
-43.10M
2025Q3
457
168.31M
97.11%
-38.09M
2025Q2
460
180.78M
105.44%
-7.40M
2025Q1
473
175.15M
102.43%
-21.99M
2024Q4
463
170.97M
101.10%
-14.45M
2024Q3
455
166.81M
103.61%
+17.06M
2024Q2
434
132.20M
98.83%
-25.01M
2024Q1
423
138.51M
105.71%
-7.14M
2023Q4
410
132.38M
103.96%
-10.79M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
SB Investment Advisers (UK) Limited
27.90M
16.1%
--
--
Sep 30, 2025
Commodore Capital LP
17.00M
9.81%
+3.65M
+27.34%
Sep 30, 2025
Point72 Asset Management, L.P.
14.77M
8.52%
+1.33M
+9.88%
Sep 30, 2025
Casdin Capital, LLC
11.34M
6.54%
-57.19K
-0.50%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
10.48M
6.05%
-143.98K
-1.35%
Sep 30, 2025
Bellevue Asset Management AG
8.35M
4.82%
+114.74K
+1.39%
Sep 30, 2025
State Street Investment Management (US)
5.07M
2.92%
-136.80K
-2.63%
Sep 30, 2025
Nextech Invest, Ltd.
3.85M
2.22%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
3.05M
1.76%
-175.08K
-5.42%
Sep 30, 2025
查看更多
ETF 市场
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Virtus LifeSci Biotech Clinical Trials ETF
1.4%
Tema Oncology ETF
0.98%
ALPS Medical Breakthroughs ETF
0.51%
State Street SPDR S&P Biotech ETF
0.33%
ProShares Ultra Nasdaq Biotechnology
0.17%
Direxion Daily S&P Biotech Bull 3X Shares
0.16%
Avantis US Small Cap Equity ETF
0.14%
Invesco Nasdaq Biotechnology ETF
0.12%
Invesco RAFI US 1500 Small-Mid ETF
0.09%
iShares Biotechnology ETF
0.08%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
占比1.4%
Tema Oncology ETF
占比0.98%
ALPS Medical Breakthroughs ETF
占比0.51%
State Street SPDR S&P Biotech ETF
占比0.33%
ProShares Ultra Nasdaq Biotechnology
占比0.17%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.16%
Avantis US Small Cap Equity ETF
占比0.14%
Invesco Nasdaq Biotechnology ETF
占比0.12%
Invesco RAFI US 1500 Small-Mid ETF
占比0.09%
iShares Biotechnology ETF
占比0.08%